Qube Research & Technologies LTD Genfit S.A. Transaction History
Qube Research & Technologies LTD
- $61.9 Billion
- Q1 2024
A detailed history of Qube Research & Technologies LTD transactions in Genfit S.A. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 98 shares of GNFT stock, worth $389. This represents 0.0% of its overall portfolio holdings.
Number of Shares
98
Previous 98
-0.0%
Holding current value
$389
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GNFT
# of Institutions
7Shares Held
76.8KCall Options Held
0Put Options Held
0-
Israel Englander Millennium Management LLC | New York, Ny29.7KShares$117,9760.0% of portfolio
-
Morgan Stanley New York, NY28.5KShares$113,0020.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il16.8KShares$66,8270.0% of portfolio
-
Optiver Holding B.V. Amsterdam, P7963Shares$3,8230.0% of portfolio
-
Rhumbline Advisers Boston, MA678Shares$2,6910.0% of portfolio
About Genfit S.A.
- Ticker GNFT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,815,500
- Market Cap $198M
- Description
- Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...